skinny.

Latest / Stock Movers

Novo Soars on Obesity Pill Approval; Huntington Ingalls Rallies; Warner Bros

On this episode of Stock Movers:

- Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term.

- Shares of naval shipmaker Huntington Ingalls (HII) rallied ahead of the US market open after President Trump announced the…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.